We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Clinical Omics – News and Features

A Rapid Genomics Strategy To Trace Coronavirus content piece image
News

A Rapid Genomics Strategy To Trace Coronavirus

Researchers have created a rapid genome sequencing strategy for the coronavirus.
Mapping the Human Proteome: A Journey content piece image
Article

Mapping the Human Proteome: A Journey

In 2020, we celebrate 90% of the human proteome being mapped by the Human Proteome Project (HPP). In this article, we reflect on the history of this endeavor and the future of the proteomics field, speaking with individuals close to the project.
Collaborations Aim To Meet Unmet Clinical Needs in Biomarker Discovery and Characterization content piece image
News

Collaborations Aim To Meet Unmet Clinical Needs in Biomarker Discovery and Characterization

Thermo Fisher Scientific announced agreements with AstraZeneca and the University of Nebraska Medical Center that will showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis.
 Breaking Down Barriers in Proteomic-Based Drug Discovery content piece image
Industry Insight

Breaking Down Barriers in Proteomic-Based Drug Discovery

SomaLogic recently announced an agreement with the biopharmaceutical company Amgen that aims to advance Amgen's drug discovery and development programs through comprehensive proteomic profiling. We spoke with Roy Smythe to discover what barriers have been holding proteome analysis back, and how the collaboration with Amgen aims to change the landscape of drug discovery.
Towards a Deeper Understanding of the Proteomic Landscape content piece image
Industry Insight

Towards a Deeper Understanding of the Proteomic Landscape

At a recent London Proteomics Discussion Group Meeting, Professor Roman Fischer kicked off the event by addressing the apparent "failure" of proteomics to deliver new clinical biomarkers thus far. Technology Networks sat down with Fischer to discuss spatial proteomics, and to expand on some of the key aspects of his research.
A Fusion of Proteomic Practices: The Indisputable Complementarity of "Bottom-Up" and "Top-Down" Approaches content piece image
Article

A Fusion of Proteomic Practices: The Indisputable Complementarity of "Bottom-Up" and "Top-Down" Approaches

In this article, we explore the two principal tracks that are used to identify and characterize proteins by mass spectrometry – "bottom-up" and "top-down" proteomics.
Differences Identified Between Blood Samples of Patients With Mild Versus Severe COVID-19 Clinical Signs content piece image
News

Differences Identified Between Blood Samples of Patients With Mild Versus Severe COVID-19 Clinical Signs

Researchers have identified 27 proteins that are present at different levels in the blood of COVID-19 patients, depending on the severity of their symptoms.
A Global Mass Spectrometry Coalition To Combat COVID-19  content piece image
Article

A Global Mass Spectrometry Coalition To Combat COVID-19

A global coalition involving over 500 scientists, known as the COVID-19 MS Coalition, was announced earlier this week. The coalition aims to share mass spectrometry data on COVID-19 for the purpose of novel biomarker discovery and understanding the infection more deeply at a molecular level. Technology Networks spoke with Perdita Barran to find out more.
Proteins in the Blood of COVID-19 Patients Could Help To Predict How Ill They Will Become content piece image
News

Proteins in the Blood of COVID-19 Patients Could Help To Predict How Ill They Will Become

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.
Developing the World's First Single Molecule Protein Sequencer content piece image
Industry Insight

Developing the World's First Single Molecule Protein Sequencer

Jagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.
Advertisement